By analyzing key variables such as hormone receptor status, molecular subtypes, tumor grade, and chemotherapy regimens, we seek to provide insights into recurrence patterns and prognostic factors, ultimately contributing to more effective, individualized treatment strategies for breast cancer patients. The gene discussed is NR4A1; the disease is breast carcinoma.